期刊文献+

结核分枝杆菌利福平耐药基因rpoB突变特征初步分析 被引量:22

Study on the characteristics of mutation on Mycobacterium tuberculosis rifampicin-resistance gene
原文传递
导出
摘要 目的阐明结核分枝杆菌利福平耐药株rpoB基因突变特点。方法对110株结核分枝杆菌临床分离株包括rpoB基因利福平耐药决定区(RRDR)81个碱基在内的286 bp片段进行聚合酶链反应-单链构象多态性(PCR-SSCP)分析,并对经检测显示有突变的结核分枝杆菌rpoB基因此扩增区域进行序列测定。其中利福平耐药株73株,非利福平耐药株11株,敏感株26株。结果PCR-SSCP检测显示利福平耐药株中有47株有突变存在,经直接测序分析其中76.6%的菌株存在rpoB基因的单位点突变,主要集中在531位(61.1%)和526位(25.0%);联合突变发生率为23.4%。此外,经PCR-SSCP检测,11株非利福平耐药株中2株有突变存在,26株敏感株中1株有突变存在。经直接测序分析突变涉及位点为511位、526位和535位。结论rpoB基因耐药决定区发生突变是结核分枝杆菌利福平耐药的主要原因,其中531位丝氨酸和526位组氨酸是最常见的突变位点。 Objective To elucidate the characters of rpoB mutation in rifampin-resistant clinical isolates of Mycobacterium tuberculosis. Methods 286 bp DNA fragment of rpoB gene including 81 bp code region (rifampin resistance deteremination region, RRDR) was analyzed by PCR-single-strand conformation polymorphism(SSCP). The 286 bp DNA fragment of each strain which had been proved to have mutation by PCR-SSCP was then sequenced. 110 strains of M. tuberculosis, including 73 rifampin- resistant strains, 11 rifampin-susceptible drug-resistant strains and 26 drug-susceptible strains were studied. Results 47 rifampin-resistant strains were detected to have mutations by PCR-SSCP method. 76.6% rifampin-resistant strains showed that rpoB gene was carrying single point mutation analyzed by direct sequencing technique, which mainly located at 531-Ser(61.1% ) and 526-His (25.0%). The combined mutation rate was 23.4 %. In addition, 2 rifampin-susceptible drug-resistant strains and 1 drug-susceptible strain were mutated, detected by PCR-SSCP method. Sequencing results showed that the mutations located at 511-Leu, 526-His and 535-Pro. Conclusion Mutations in the 81 bp RRDR of rpoB were the main reasons of M. tuberculosis resistant to rifampin. 531-Ser and 526-His were the most common positions of mutations.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2006年第11期973-976,共4页 Chinese Journal of Epidemiology
基金 国家自然科学基金资助项目(30471526)
关键词 结核分枝杆菌 耐药 聚合酶链反应-单链构象多态性 Mycobacterium tuberculosis Drug resistance PCR-single-strand conformation polymorphism
作者简介 通讯作者:万康林,Email:wankanglin@icdc.cn
  • 相关文献

参考文献8

  • 1World Health Organization.International Union Against Tuberculosis and Lung Disease.Anti-tuberculosis drug resistance in the world:The WHO/ IUATLD global project on anti-tuberculosis drug resistance surveillance:Report No.2.Prevalence and Trends.Geneva:WHO/IUATLD,2000.1-107.
  • 2全国结核病流行病学抽样调查技术指导组.2000年全国结核病流行病学抽样调查报告[J].中国防痨杂志,2002,24(2):65-108. 被引量:1378
  • 3Drobniewski FA,Wilson SM.The rapid diagnosis of isoniazid and rifampin resistance in Mycobacterium tuberculosiss-a molecular story.J Med Microbiol,1998,47:189-196.
  • 4Watterson SA,Wilson SM,Yates MD,et al.Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis.J Clin Microl,1998,36:1969-1973.
  • 5Mitchison DA.Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.Am Rev Respir Dis,1986,133:423-430.
  • 6Telenti A,Imboden P,Marchesi F,et al.Detection of rifampinresistance mutations in Mycobacterium tuberculosis.Lancet,1993,341:647-650.
  • 7Mark T McCammon,John S Gillette,Derek P,et al.Detection of rpoB Mutation Associated with Rifampin Resistance in Mycobacterium tuberculosis Using Denaturing Gradient Gel Electrophoresis.Antimicrobial Agents and Chemotherapy,2005,49:2000-2009.
  • 8乐军,曾而良,谢建平,李瑶,梁莉,王洪海.中国耐多药结核分枝杆菌临床分离株rpoB基因突变特点[J].Acta Genetica Sinica,2004,31(12):1332-1336. 被引量:23

二级参考文献26

  • 1张敦熔.耐药性的流行病学意义[J].中国防痨杂志,1997,4:155-155.
  • 2全国结核病流行病学抽样调查领导小组.1979全国结核病流行病学抽样调查综合简报[J].中国防痨通讯,1982,2:3-6.
  • 3中华人民共和国卫生部.1984/1985全国结核病流行病学抽样调查资料汇编[M].,-.18-19.
  • 4Espinal M A,Laszlo A,Simonsen L,Boulahbal F,Kim S J,Reniero A,Hoffner S,Rieder H L,Binkin N,Dye C,Williams R,Raviglione M C.Global trends in resistance to antituberculosis drugs.N Engl J Med,2001,344(17):1294~1303.
  • 5Dye C,Williams B G,Espinal M A,Raviglione M C.Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.Science,2002,295(5562):2042~2046.
  • 6Becerra M C,Bayona J,Freeman J,Farmer P E,Kim J Y.Redefining MDR-TB transmission-drug resistance'hot spots'.Int J Tuberc Lung Dis,2000,4(5): 387~394.
  • 7Dye C,Scheele S,Dolin P,Pathania V,Raviglione M C.Consensus statement.Global burden of tuberculosis: estimated incidence,prevalence,and mortality by country.WHO Global Surveillance and Monitoring Project.JAMA,1999,18:677~686.
  • 8Dye C,Williams B G.Criteria for the control of drug-resistant tuberculosis.Proc Natl Acad Sci USA,2000,97(14):8180~8185.
  • 9Drobniewski F A,Wilson S M.The rapid diagnosis of isoniazid and rifampin resistance in Mycobacterium tuberculosis--a molecular story.J Med Microbiol,1998,47(3): 189~196.
  • 10Ramaswamy S,Musser J M.Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis:1998 update.Tuberc Lung Dis,1998,79:3~29.

共引文献1398

同被引文献188

引证文献22

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部